RE:RE:RE:Polish Researchers Cite Rutherrin PDT for Brain CancerYes it does seem ludicrous. Having an sp of 23 cents CAN at this stage of the game also seems ludicrous. Could big pharma.anti-PDT prejudice really be that strong? At some point some corporate sharpie is going to realize that a lot of money.could be made here. Or maybe they already realize it? If so, why are they risking a rival getting in first?
StevenBirch wrote: As I have said it's my opinion that it would be a waste of time raising $462K unless it was only to get them through this next quarter with the expectation that they will be able raise money for GBM or NSCLC from a much more favorable position. If the time frame were longer they would be forced to do a deal with the devil but we know from this last update that they are close to getting BTD. The idea that they were begging for money and all they could get was $462K seems ludicrous to me given what they have achieved in this trial and what they have on the go.
Oilminerdeluxe wrote: Now that is a study I want to see start asap. That little thing called money though. Hopefully soon solved.